OncoCyte Accounts Payable from 2010 to 2024

OCX Stock  USD 2.44  0.09  3.56%   
OncoCyte Corp Accounts Payable yearly trend continues to be fairly stable with very little volatility. Accounts Payable will likely drop to about 621.2 K in 2024. Accounts Payable is the amount OncoCyte Corp owes to suppliers or vendors for products or services received but not yet paid for. It represents OncoCyte Corp's short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2013-12-31
Previous Quarter
1.1 M
Current Value
872 K
Quarterly Volatility
950 K
 
Yuan Drop
 
Covid
Check OncoCyte Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among OncoCyte Corp's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 M, Interest Expense of 49.4 K or Selling General Administrative of 11.2 M, as well as many indicators such as Price To Sales Ratio of 12.09, Dividend Yield of 0.0015 or PTB Ratio of 0.71. OncoCyte financial statements analysis is a perfect complement when working with OncoCyte Corp Valuation or Volatility modules.
  
Check out the analysis of OncoCyte Corp Correlation against competitors.
For more information on how to buy OncoCyte Stock please use our How to Invest in OncoCyte Corp guide.

Latest OncoCyte Corp's Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of OncoCyte Corp over the last few years. An accounting item on the balance sheet that represents OncoCyte Corp obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of OncoCyte Corp are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. OncoCyte Corp's Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in OncoCyte Corp's overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Slightly volatile
   Accounts Payable   
       Timeline  

OncoCyte Accounts Payable Regression Statistics

Arithmetic Mean476,147
Geometric Mean301,422
Coefficient Of Variation105.41
Mean Deviation364,348
Median285,000
Standard Deviation501,905
Sample Variance251.9B
Range1.7M
R-Value0.71
Mean Square Error134.9B
R-Squared0.50
Significance0
Slope79,576
Total Sum of Squares3.5T

OncoCyte Accounts Payable History

2024621.2 K
2023953 K
20221.3 M
20211.8 M
2020432 K
2019469 K
2018166 K

About OncoCyte Corp Financial Statements

OncoCyte Corp investors use historical fundamental indicators, such as OncoCyte Corp's Accounts Payable, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in OncoCyte Corp. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Accounts Payable953 K621.2 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for OncoCyte Stock Analysis

When running OncoCyte Corp's price analysis, check to measure OncoCyte Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OncoCyte Corp is operating at the current time. Most of OncoCyte Corp's value examination focuses on studying past and present price action to predict the probability of OncoCyte Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OncoCyte Corp's price. Additionally, you may evaluate how the addition of OncoCyte Corp to your portfolios can decrease your overall portfolio volatility.